Hyperbaric treatment schedules
Hyperbaric Treatment Schedules
Hyperbaric treatment schedules refer to the specific protocols and regimens used in hyperbaric oxygen therapy (HBOT) to treat various medical conditions. These schedules are designed to optimize the therapeutic benefits of HBOT by controlling the duration, frequency, and pressure of oxygen exposure.
Overview[edit | edit source]
Hyperbaric oxygen therapy involves breathing pure oxygen in a pressurized room or chamber. The increased pressure allows more oxygen to dissolve in the blood, which can enhance healing and fight infection. The treatment schedules are tailored to the specific condition being treated, the patient's overall health, and the response to therapy.
Common Treatment Schedules[edit | edit source]
The treatment schedules can vary widely depending on the condition being treated. Some of the common conditions treated with HBOT and their typical schedules include:
- Decompression sickness: Often treated with a series of sessions at 2.8 atmospheres absolute (ATA) for 4-6 hours.
- Carbon monoxide poisoning: Typically involves 3-5 sessions at 2.5-3.0 ATA for 90 minutes each.
- Chronic non-healing wounds: Usually treated with 20-40 sessions at 2.0-2.5 ATA for 90 minutes each.
- Radiation injury: Often requires 30-40 sessions at 2.0-2.5 ATA for 90 minutes each.
Factors Influencing Treatment Schedules[edit | edit source]
Several factors influence the design of hyperbaric treatment schedules, including:
- The specific medical condition being treated.
- The severity and duration of the condition.
- The patient's age, overall health, and medical history.
- The response to initial HBOT sessions.
Safety and Monitoring[edit | edit source]
During HBOT, patients are closely monitored for any adverse effects. Common side effects include ear barotrauma, sinus pain, and temporary vision changes. Serious complications are rare but can include oxygen toxicity and lung barotrauma.
Conclusion[edit | edit source]
Hyperbaric treatment schedules are a critical component of HBOT, tailored to maximize therapeutic benefits while minimizing risks. Proper scheduling and monitoring are essential for the safe and effective use of this therapy.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
